Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ADIL Stock Forecast, Price Targets, Chart, Dividends & Analysis

Adial Pharmaceuticals Inc logo

Adial Pharmaceuticals Inc

Sector: Healthcare   

Industry: Biotechnology

1.07
 
USD
  
0.02
  
(1.90%)
Previous close: 1.05  Open: 1.04  Bid: 1.0  Ask: 1.05
52 week range    
0.77   
   4.17
Mkt Cap: 7 M  Avg Vol (90 Days): 167,601
Peers   
NWBO / 
NYMX / 
OHCS / 
Last updated: Sunday 22nd December 2024

Stock Rankings

51
MarketXLS Rank
80
Value
46
Technical
28
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

NWBO

NYMX

0.2

OHCS

OMIC

0 B-119.55
Financials

ADIL Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AcquisitionExpense46000.046000.0
Amortization of intangibles-563.0-565.0248971.0248971.0
Basic EPS from continuing operations-21.75-26.0-12.75-8.51
Basic EPS total-21.75-26.0-12.75-3.6
Basic weighted shares outstanding5 M394099.0498525.0743549.01 M1 M
BasicDiscontinuousOperations1.32
Cost of sales550000.0
Diluted EPS total-2.44-21.75-21.75-26.0-12.75-3.6
Diluted normalized net income/share-12.75-4.91
Diluted weighted shares outstanding243182.0395008.0498525.01 M1 M
DilutedDiscontinuousOperations1.32
Fees450000.0
GainOnSaleOfSecurity-281713.0522000.0
GeneralAndAdministrativeExpense7 M4 M5 M9 M9 M6 M
Gross operating profit-415031.0450000.0
ImpairmentOfCapitalAssets2 M
Income before tax-12 M-9 M-11 M-20 M-13 M-7 M
Income taxes0.0225900.0-446351.0-94077.0-502.0690035.0
Interest income7392.0-346529.032495.06539.063338.069779.0
InterestExpenseNonOperating1 M
MiscOtherSpecialCharges-3 M2500.046494.063338.0-183722.0
Net income from total operations-12 M-9 M-11 M-19 M-13 M-5 M
NetIncomeCommonStockholders-12 M-9 M-11 M-19 M-13 M-5 M
NetIncomeContinuousOperations-12 M-9 M-11 M-19 M-13 M-5 M
NetIncomeDiscontinuousOperations-2 M2 M
NetNonOperatingInterestIncomeExpense-1 M-346529.032495.06539.0-63209.069779.0
Normalized income-6 M
Operating income-7 M-8 M-11 M-19 M-11 M-7 M
Operating income before depreciation (EBITDA)-10 M-9 M-11 M-18 M-13 M-7 M
OperatingExpense-7 M-8 M11 M19 M13 M7 M
Other income net3 M-2500.0235219.0522000.0183722.0
Other special charges-376000.0
OtherGainLossFromDispositionOfDiscontinuedOperations-2 M2 M
OtherGandA7 M4 M5 M9 M9 M6 M
OtherOperatingExpenses-1 M40000.075116.0398600.07 M
RentAndLandingFees7 M4 M-1400.0-1400.0
Research & development expense368459.04 M6 M8 M2 M1 M
ResearchExpense368459.04 M6 M8 M2 M1 M
Revenue per share-353236.0-565.0248971.0248971.0
SalariesAndWages-5 M-2 M2 M375000.0416200.0435000.0
Selling Gen & administrative expense7 M4 M5 M9 M9 M6 M
Special income/charges376000.0-2 M
Total Income available for interest expense (EBIT)-10 M-9 M-11 M-18 M-13 M-7 M
Total common shares outstanding419184.0690795.0948758.01 M
Total net income-12 M-9 M-11 M-19 M-13 M-5 M
Total ordinary shares6 M6 M6 M6 M6 M6 M
Total revenues134969.0450000.0
TotalExpenses-7 M-8 M11 M19 M13 M7 M
TotalRevenue134969.0450000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University